3171 results for «3252»
3171 results
Challenging tricuspid TEER cases
22 May 2025 – From EuroPCR 2025
Explore challenging tricuspid transcatheter edge-to-edge repair (TEER) cases highlighting combined LAA occlusion and mitral valve repair, anatomical complexities, and strategies to complete surgical interventions percutaneously. Discuss the balance between procedural perfection and clinical practicality in complex valve anatomies.
A central role for cardiac imaging in transcatheter LAA closure
22 May 2025 – From EuroPCR 2025
Discover the central role of cardiac imaging in transcatheter left atrial appendage (LAA) closure. This session covers sealing techniques, advances in cardiac tomography for assessing LAA wall thickness, fusion of 3D computational modeling with fluoroscopy guidance, device healing evaluation through early serial imaging, and complex cases...
Optimal acute heart failure care: must have, must do
22 May 2025 – From EuroPCR 2025
This session presents must-have strategies for optimal acute heart failure care. Topics include establishing an extracorporeal cardiopulmonary resuscitation referral center with patient outcomes, percutaneous closure in ventricular septal rupture, modified manual compression for large-bore sheaths, antithrombotic therapy considerations in AMI complicated by cardiogenic shock with mechanical...
Optimal SCAD treatment
22 May 2025 – From EuroPCR 2025
Navigate the complexities of spontaneous coronary artery dissection (SCAD) treatment through clinical case discussions. This session explores identifying the culprit lesion, recurrent ACS challenges, the conservative versus PCI treatment dilemma, and real-world presentation scenarios emphasizing decision-making in SCAD management.
PCI in a challenging coronary anatomy
22 May 2025 – From EuroPCR 2025
This session tackles PCI in challenging coronary anatomies, featuring cases with anomalous coronary arteries, complex access routes, and specialized stenting techniques. Learn from experiences managing dual anomalous arteries, navigating to difficult lesions, and applying innovative modified chimney stent methods to restore coronary flow.
Combined LAA closure and transcatheter mitral valve repair - LIVE Case
22 May 2025 – From EuroPCR 2025
An 82-year-old male patient with a history of PM (pacemaker) implantation in 2024, and ischaemic cardiomyopathy presented with symptomatic heart failure due to severe secondary mitral regurgitation and impaired LV function (EF 40 %). He also presented with recurrent gastro-intestinal bleeding while on DOAC for atrial...
Redo TAVI - How to treat different TAVI platforms when they fail
22 May 2025 – From EuroPCR 2025
Understand the complexities of redo TAVI procedures with emphasis on planning, valve platform characteristics, and tailored procedural strategies. This session features cases of redo TAVI for failed short-frame and tall-frame valves, alongside discussions on current evidence gaps guiding optimal management.
High thrombus burden in STEMI
22 May 2025 – From EuroPCR 2025
This session addresses the management of high thrombus burden in STEMI patients. It reviews available tools and strategies for thrombus management, presents multiple case-based discussions illustrating treatment decisions, and explores the evolving role of thrombus aspiration in contemporary practice.
Beyond the intervention: outcomes of CTO PCI
22 May 2025 – From EuroPCR 2025
Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.
Risk stratification of NSTEMI patients
22 May 2025 – From EuroPCR 2025
Explore the latest insights on risk stratification in NSTEMI patients through comparative analysis of established risk scores such as GRACE, HEART, and TIMI in predicting coronary artery disease severity. This session also reviews outcomes based on diabetes status and left ventricular ejection fraction, prospective validation of...
TAVI - Outcomes predictors
22 May 2025 – From EuroPCR 2025
Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.
Retrograde removal of the broken sheath
22 May 2025 – From EuroPCR 2025
This session addresses complex complications during vascular access with a focus on retrograde removal of broken sheaths. Learn to recognize critical signs, manage rare but severe complications including broken guidewires in the radial artery, and explore innovative off-label solutions for challenging scenarios.
TAVI for aortic regurgitation off label
22 May 2025 – From EuroPCR 2025
Explore off-label applications of TAVI for aortic regurgitation in complex clinical scenarios. Topics include TAV-in-SAV with Trilogy valve for severe regurgitation, challenges of transcatheter prosthesis in pure aortic regurgitation, management of surgical valve perforations, and treatment strategies in post-surgical anatomies including degenerative homografts and aortic dissection.
Acute complications during distal left main PCI - Part 3
22 May 2025 – From EuroPCR 2025
This session highlights acute complications during distal left main PCI. It presents cautionary cases of incorrect left main stenting, catastrophic left main V stenting outcomes, unprotected left main thrombosis, and survival strategies when new technologies fail unexpectedly.
Percutaneous And Non-fluoroscopic Procedures (PAN): promoting equality and radiation-free intervention
22 May 2025 – From EuroPCR 2025
Discover innovative non-fluoroscopic interventional techniques with the Percutaneous And Non-fluoroscopic Procedures (PAN) session. Learn how to perform radiation-free interventions using advanced technologies, assess their clinical equivalence to standard methods, and explore how these procedures may promote gender equality in interventional cardiology careers.
Peripheral interventions: the hidden key for complications
22 May 2025 – From EuroPCR 2025
Uncover the critical role of peripheral interventions in managing complications. This session shares case stories of lost stents, unusual TAVI access complications, percutaneous removal of misplaced devices, revascularisation of iatrogenic pseudoaneurysms, and challenges when multiple closure devices are insufficient.
TAVI and coronary artery disease
22 May 2025 – From EuroPCR 2025
Examine the evolving role of coronary artery disease assessment in TAVI patients. This session compares coronary tomography and angiography for pre-TAVI evaluation, reviews safety and effectiveness of CT angiography-based strategies, and introduces the UNICORN procedure for managing high coronary obstruction risk in complex TAVI scenarios including...
Electrosurgical techniques in transcatheter mitral valve replacement
22 May 2025 – From EuroPCR 2025
Delve into electrosurgical techniques in transcatheter mitral valve replacement. This session covers advanced methods including the tip-to-base lampoon technique, electrosurgical laceration of failed devices, left ventricular outflow tract obstruction management, combined septal ablation and valve-in-valve procedures, and management of severe aortic regurgitation post-laceration.
High-risk PCI in acute coronary syndrome
22 May 2025 – From EuroPCR 2025
Explore high-risk PCI strategies in acute coronary syndrome patients who are unsuitable for surgery. This session presents insights on Killip class influence, haemodynamic support with micro-axial flow pumps, disease progression patterns in complicated STEMI, and the prognostic value of QFR-guided functional SYNTAX scores in ACS management.
Emerging indications for TAVI in 2025
22 May 2025 – From EuroPCR 2025
Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.
